Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $4.1900 (-0.71%) ($4.1500 - $4.1900) on Thu. Mar. 31, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.57% (three month average) | RSI | 65 | Latest Price | $4.1900(-0.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -0.9% a day on average for past five trading days. | Weekly Trend | AUTL advances 1.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) XBI(72%) IBB(66%) XHB(59%) IBUY(56%) IWO(54%) | Factors Impacting AUTL price | AUTL will decline at least -1.785% in a week (0% probabilities). TIP(-50%) TLT(-27%) SHY(-23%) UNG(-17%) SLV(-12%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.785% (StdDev 3.57%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $4.21(-0.48%) | 10 Day Moving Average | $4.27(-1.87%) | 20 Day Moving Average | $4.09(2.44%) | To recent high | -23.3% | To recent low | 19.5% | Market Cap | $219m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |